"Saccharomyces cerevisiae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement.
| Descriptor ID |
D012441
|
| MeSH Number(s) |
B01.300.107.795.785.800 B01.300.930.705.655
|
| Concept/Terms |
Saccharomyces cerevisiae- Saccharomyces cerevisiae
- Yeast, Baker's
- Yeast, Baker
- Yeast, Bakers
- Baker Yeast
- Baker Yeasts
- Yeasts, Baker
- Yeast, Brewer's
- Yeast, Brewer
- Yeast, Brewers
- S cerevisiae
- Baker's Yeast
- Baker's Yeasts
- Bakers Yeast
- Yeasts, Baker's
- Brewer's Yeast
- Brewer Yeast
- Brewer's Yeasts
- Brewers Yeast
- Yeasts, Brewer's
|
Below are MeSH descriptors whose meaning is more general than "Saccharomyces cerevisiae".
Below are MeSH descriptors whose meaning is more specific than "Saccharomyces cerevisiae".
This graph shows the total number of publications written about "Saccharomyces cerevisiae" by people in this website by year, and whether "Saccharomyces cerevisiae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 3 | 3 |
| 2006 | 1 | 2 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 2 | 3 |
| 2009 | 2 | 1 | 3 |
| 2011 | 3 | 2 | 5 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 0 | 1 | 1 |
| 2017 | 12 | 12 | 24 |
| 2018 | 15 | 7 | 22 |
| 2019 | 2 | 5 | 7 |
| 2020 | 1 | 4 | 5 |
| 2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Saccharomyces cerevisiae" by people in Profiles.
-
Rapid generation of potent antibodies by autonomous hypermutation in yeast. Nat Chem Biol. 2021 10; 17(10):1057-1064.
-
Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis. Cell Chem Biol. 2021 09 16; 28(9):1379-1388.e7.
-
Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA). Cell Mol Immunol. 2021 08; 18(8):1847-1860.
-
A comprehensive library of fluorescent constructs of SARS-CoV-2 proteins and their initial characterisation in different cell types. Biol Cell. 2021 Jul; 113(7):311-328.
-
Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice. Microb Cell Fact. 2021 May 05; 20(1):95.
-
Yeast proteins do not practice social distancing as species hybridize. Curr Genet. 2021 Oct; 67(5):755-759.
-
Immunomodulating Effects of Fungal Beta-Glucans: From Traditional Use to Medicine. Nutrients. 2021 Apr 17; 13(4).
-
SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Hum Vaccin Immunother. 2021 08 03; 17(8):2356-2366.
-
Perfect Match Genomic Landscape strategy: Refinement and customization of reference genomes. Proc Natl Acad Sci U S A. 2021 04 06; 118(14).
-
Rescue of Infectious Sindbis Virus by Yeast Spheroplast-Mammalian Cell Fusion. Viruses. 2021 04 01; 13(4).